Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FRA/NVV1 stock hub

FRA/NVV1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/NVV1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/NVV1

In the news

Latest news · FRA/NVV1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROEn/a

P25 -6.7P50 8.5P75 17.2

ROIC15.3

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/NVV1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	749
Employees Change	-591%
Employees Change Percent	-38.3
Enterprise value	EUR 991.6M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US6700024010
Last refreshed	2026-05-10
Market cap	EUR 1.4B
Price	EUR 8.89
Price currency	EUR
Rev Per Employee	690,525.96x
Sector	Healthcare
Sic	2836
Symbol	fra/NVV1
Website	https://www.novavax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.39%
EV Earnings	-13.02x
EV/EBIT	31.38x
EV/EBITDA	17.15x
EV/FCF	-11.81x
EV/Sales	1.96x
FCF yield	-5.94%
P/B ratio	-11.25x
P/S ratio	2.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.24%
EBITDA Margin	9.98%
Gross margin	27.49%
Gross Profit	EUR 142.2M
Gross Profit Growth	-77.38%
Gross Profit Growth Q	-95.3%
Net Income	EUR -76.2M
Net Income Growth Years	4%
Pretax Margin	-14.45%
Profit Margin	-14.73%
Profit Per Employee	EUR -101,708
Profitable Years	1
ROA	1.99
Roa5y	-13.46
ROCE	5.31
ROIC	15.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.6%
Cagr15y	-7.96%
Cagr1y	69.95%
Cagr20y	-11.11%
Cagr3y	8.54%
Cagr5y	-42.91%
EPS Growth Years	4
Revenue Growth	-52.48x
Revenue Growth Q	-79.07x
Revenue Growth Years	2x
Revenue Growth3 Y	-24.01x
Revenue Growth5 Y	-8.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.51
Assets	EUR 904.7M
Cash	EUR 685.5M
Current Assets	EUR 721.5M
Current Liabilities	EUR 290.4M
Debt	EUR 255.9M
Debt EBITDA	EUR 4.34
Debt FCF	EUR -3.05
Equity	EUR -125.6M
Interest Coverage	1.65
Liabilities	EUR 1B
Long Term Assets	EUR 183.3M
Long Term Liabilities	EUR 739.9M
Net Cash	EUR 429.6M
Net Cash By Market Cap	EUR 30.41
Net Cash Growth	-1.5%
Net Debt EBITDA	EUR -8.32
Tangible Book Value	EUR -223.5M
Tangible Book Value Per Share	EUR -1.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.48
Inventory Turnover	39.81
Net Working Capital	EUR -242.7M
Quick ratio	2.38
Working Capital	EUR 440.9M
Working Capital Turnover	EUR 1.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-88.71%
1Y total return	69.88%
200-day SMA	7.07
3Y total return	27.88%
50-day SMA	7.82
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.93%
All Time High	274.2
All Time High Change	-96.76%
All Time High Date	2021-02-08
All Time Low	3.3
All Time Low Change	169.39%
All Time Low Date	2019-11-21
ATR	0.4
Ch YTD	54.61
High	9.05
High52	10.03
High52 Date	2026-02-26
High52ch	-11.35%
Low	7.95
Low52	5.25
Low52 Date	2025-05-12
Low52ch	69.37%
Ma50ch	13.74%
Price vs 200-day SMA	25.74%
RSI	67.67
RSI Monthly	46.65
RSI Weekly	58.88
Sharpe ratio	0.89x
Sortino ratio	1.59
Total Return	-0.58%
Tr YTD	54.61
Tr15y	-71.19%
Tr1m	32.69%
Tr1w	29.78%
Tr3m	31.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 32.3M
Operating Income Growth	-91.2
Operating margin	6.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	141,464,301%
Net Borrowing	68,319,450.4
Shares Insiders	0.84%
Shares Institutions	58.36%
Shares Qo Q	-1.15%
Shares Yo Y	0.58%
Short Ratio	10.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -113M
Average Volume	5,717.35x
Bv Per Share	-0.76
CAPEX	EUR -4.5M
Ch10y	-88.71
Ch15y	-71.19
Ch1m	32.69
Ch1w	29.78
Ch1y	69.88
Ch20y	-90.52
Ch3m	31.86
Ch3y	27.88
Ch5y	-93.93
Ch6m	34.9
Change	13.39%
Change From Open	11.82
Close	7.84
Days Gap	1.4
Depreciation Amortization	18,939,231.3
Dollar Volume	386,803.9
Earnings Date	2026-05-06
EBIT	EUR 32.3M
EBITDA	EUR 51.6M
EPS	EUR -0.47
F Score	2
FCF	EUR -83.9M
FCF EV Yield	-8.47x
Financing CF	62,855,833
Fiscal Year End	December
Founded	1,987
Goodwill	95,724,734.3
Income Tax	EUR 1.4M
Investing CF	-28,888,896
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2019-05-10
Last Split Type	Reverse
Ma150	7.15
Ma150ch	24.41%
Ma20	7.22
Ma20ch	23.06%
Net CF	-39,509,852
Open	7.95
Position In Range	85.45
Ppne	53,851,522.7
Price Date	2026-05-08
Price EBITDA	EUR 27.36
Relative Volume	12.43x
Revenue	517,203,947x
SBC By Revenue	5.61x
Share Based Comp	29,014,654
Tax By Revenue	0.28x
Tr20y	-90.52%
Tr6m	34.9%
Volume	43,510
Z Score	-4.23

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/NVV1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/NVV1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/NVV1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.4%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/NVV1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.7

Neutral momentum band

Price vs 200-day MA

+25.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/NVV1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/NVV1 stock rating?

fra/NVV1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/NVV1 analysis?

The full report lives at /stocks/fra/NVV1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/NVV1?

The latest report frames fra/NVV1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/NVV1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.